Abstract
The amyloid protein precursor (APP) can be processed via several alternative processing pathways, α-secretase processing by cleavage within the amyloid β-peptide domain of APP is highly regulated by several external and internal signals including G protein-coupled receptors, protein kinase C and phospholipase A2. In order to demonstrate that G protein-coupled neuropeptide receptors for bradykinin and vasopressin can increase α-secretase processing of APP, we stimulated endogenously expressed bradykinin or vasopressin receptors in cell culture with the neuropeptides and measured the secreted ectodomain (APPs) in the conditioned media. Both bradykinin and vasopressin rapidly increased phosphatidylinositol (PI) turnover in PC-12 and in NRK-49F cells, indicating that these cell lines constitutively expressed functional PI-linked receptors for these neuropeptides. Both bradykinin and vasopressin readily stimulated APPs secretion. Increased APPs secretion was concentration-dependent and saturable, and it was blocked by receptor antagonists indicating specific receptor interaction of the peptides. The bradykinin-induced increase in APPs secretion in PC-12 cells was mediated by protein kinase C (PKC), whereas vasopressin receptors in NRK-49F cells were coupled to APP processing by PKC-independent signalling pathways. Our data show that neuropeptides can modulate APP processing in cell culture. In as much as increased α-secretase processing is associated with decreased formation of Aβ1–40, a major constituent of amyloid plaques, our findings suggest a possible role for modulating neuropeptide receptors as a strategy for altering amyloid metabolism in Alzheimer's disease brain.
Similar content being viewed by others
REFERENCES
Borkowski, J. A., Ransom, R. W., Seabrook, G. R., Trumbauer, M., Chen, H., Hill, R. G., Strader, C. D., and Hess, J. F. 1995. Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J. Biol. Chem. 270:13706–13710.
Jones, S., Brown, D. A., Milligan, G., Willer, E. Buckley, N. J. and Caulfield, M. P. 1995. Bradykinin excited rat sympathetic neurons by inhibition of M current through a mechanism involving B2 receptors and G alpha q/11. Neuron 14:399–405.
Weinreich, D., Koschorke, G. M., Undem, B. J., and Taylor, G. E. 1995. Prevention of the excitatory actions of bradykinin by inhibition of PG12 formation in nodose neurones of the guinea pig. J. Physiol. 483:735–746.
Cholewinski, A. J., Stevens, G., McDermott, A. M., and Wilkin, G. P. 1991. Identification of B2 bradykinin binding sites on cultured cortical astrocytes. J. Neurochem. 57:1456–1458.
Issandou, M. and Dorbon, J.-M. 1991. Des-Arg9 bradykinin modulates DNA synthesis, phospholipase C, and protein kinase C in cultured mesangial cells. J. Biol. Chem. 266:21037–21043.
Suh, B. C., Lee, C. O., and Kim, K. T. 1995. Signal flows from two phospholipase C-linked receptors are independent in PC-12 cells. J. Neurochem. 64:1071–1079.
Lee, K.-M., Toscas, K., and Villerereal, M. L. 1993. Inhibition of bradykinin-and thapsigargin-induced Ca2+ entry by tyrosine kinase inhibitors. J. Biol. Chem. 268:9945–9948.
McEachern, A. E., Shelton, E. R., Bhakta, S., Obemolte, R., Bach, C., Zuppan, P., Fujisaki, J., Aldrich, R. W., and Jarnagin, K. 1991. Expression cloning of a rat B2 bradykinin receptor. Proc. Natl. Acad. Sci. USA 88:7724–7728.
Menke, J. G., Borkowski, J. A., Bierilo, K. K., MacNeil, T., Derrick, A. W., Schneck, K. A., Ransom, R. W., Strader, C. D., Linemeyer, D. L., and Hess, J. F. 1994. Expression cloning of a human B1 bradykinin receptor. J. Biol. Chem. 269:21583–21586.
Nardone, J., Gerald, C., Rimawi, L., Song, L., and Hogan, P. G. 1994. Identification of a B2 bradykinin receptor expressed by PC12 pheochromocytoma cells. Proc. Natl. Acad. Sci. USA 91:4412–4416.
Morel, A., O'Carroll, A.-M., Brownstein, M. J., and Lolait, S. J. 1992. Molecular cloning and expression of a rat V1a arginine vasopressin receptor. Nature 356:356–526.
Briley, E. M., Lolait, S. J., Axelrod, J., and Felder, C. C. 1994. The cloned vasopressin V1a receptor stimulates phospholipase A2, phospholipase C, and phospholipase D through activation of receptor-operated calcium channels. Neuropeptides 27:63–74.
Lolait, S. J., O'Carroll, A. M., Mahan, L. C., Felder, C. C., Button, D. C., Young, W. S. 3rd., Mezey, E., and Brownstein, W. J. 1995. Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc. Natl. Acad. Sci. USA 92:6783–6787.
Ostrowski, N. L., Lolait, S. J., and Young, W. S. 3rd 1994. Cellular localization of vasopressin V1a receptor messenger ribonucleic acid in adult male rat brain. Endocrinology 135:1511–1528.
Lolait, S. J., O'Carroll, A.-M., McBride, O. W., Konig, M., Morel, A., and Brownstein, M. J. 1992. Cloning and characterization of a vasopressin V2 receptor; chromosomal localization of gene suggests link to hereditary nephrogenic diabetes insipidus. Nature 357:336–339.
Sisodia, S. S., Koo, E. H., Beyreuther, K., Unterbeck, A., and Price, D. L. 1990. Evidence that β-amyloid protein of Alzheimer's disease is not derived by normal processing. Science 248:492–495.
Hung, A. Y., Haass, C., Nitsch, R. M., Qiao Qiu, W., Citron, M., Wurtman, R. J., Growdon, J. H., and Selkoe, D. J. 1993. Activation of protein kinase C inhibits cellular production of the amyloid β-protein. J. Biol. Chem. 268:22959–22962.
Gabuzda, D., Busciglio, J., and Yankner, B. A. 1993. Inhibition of β-amyloid production by activation of protein kinase C. J. Neurochem. 61:2326–2329.
Wolf, B. A., Wertkin, A. M., Jolly, Y. C., Yasuda, R. P., Wolfe, B. B., Konrad, R. J., Manning, D., Ravi, S., Williamson, J. R., and Lee, V. M. Y. 1995. Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid beta-protein production in human neuronal NT2N cells. J. Biol. Chem. 270:4916–4922.
Farber, S. A., Nitsch, R. M., Schulz, J. G., and Wurtman, R. J. 1995. Regulated secretion of β-amyloid precursor protein in rat brain. J. Neurosci. 15:7442–7450.
Nitsch, R. M. and Growdon, J. H. 1994. Role of neurotransmission in the regulation of amyloid β-protein precursor processing. Biochem. Pharmacol. 47:1275–1284.
Nitsch, R. M., Slack, B. E., Wurtman, R. J., and Growdon, J. H. 1992. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258:304–307.
Nitsch, R. M., Deng, M., Growdon, J. H., and Wurtman, R. J. 1996. Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion. J. Biol. Chem. 271:4188–4194.
Nitsch, R. M., Deng, A., Wurtman, R. J., and Growdon, J. H. 1997. Metabotropic glutamate receptor subtype mGluR1α stimulates the secretion of the amyloid beta protein precursor ectodomain. J. Neurochem. in press.
Nitsch, R. M., Farber, S. A., Growdon, J. H., and Wurtman, R. J. 1993. Release of amyloid β-protein precursor derivatives from hippocampal slices by electrical depolarization. Proc. Natl. Acad. Sci. USA 90:5191–5193.
Lee, R. K. K., Wurtman, R. J., Slack, B. E., Cox, A. J., and Nitsch, R. M. 1995. Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Proc. Natl. Acad. Sci. USA 92:8083–8087.
Emmerling, M. R., Moore, C. J., Doyle, P. D., Carroll, R. T., and Davis, R. E. 1993. Phospholipase A2 activation influences the processing and secretion of the amyloid precursor protein. Biochem. Biophys. Res. Commun. 197:292–297.
Slack, B. E., Breu, J., Petryniak, M. A., Srivastava, K., and Wurtman, R. J. 1995. Tyrosine phosphorylation-dependent stimulation of amyloid precursor protein secretion by the m3 muscarinic aceltylcholine receptor. J. Biol. Chem. 270:8337–8344.
Slunt, H. H., Thinakaran, G., Von Koch, C., Lo, A. C. Y., Tanzi, R. E., and Sisodia, S. S. 1994. Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP). J. Biol. Chem. 269:2637–2644.
Xu, H., Greengard, P., and Gandy, S. 1995. Regulated formation of Golgi secretory vesicles containing Alzheimer beta-amyloid precursor protein. J. Biol. Chem. 270:23243–23245.
Milward, E. A., Papadopoulos, R., Fuller, S. J., Moir, R. D., Small, D., Beyreuther, K., and Masters, C. L. 1992. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron 9:129–137.
Zheng, H., Jiang, M. H., Trumbauer, M. E., Sirinathsinghji, D. J. S., Hopkins, R., Smith, D. W., Heavens, R. P., Dawson, G. R., Boyce, S., Conner, M. W., Stevens, K. A., Slunt, H. H., Sisodia, S. S., Chen, H. Y., and Van der Ploeg, L. H. T. 1995. Beta-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81:525–531.
Goate, A. Chartier-Harlin, M.-C. Mullan, M. Broen, J. Crawford, F. Fidani, L. Giuffra, L. Hayes, A. Irving, N. James, L. Mant, R. Newton, P. Rooke, K. Roques, P. Talbot, C. Pericak-Vance, M. Roses, A. Williamson, R. Rossor, M. Owen, M., and Hardy, J. 1991. Segregation of a missense mutation in the amyloid precursor gene with familial Alzheimer's disease. Nature 349:704–706.
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanan, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D., and Younkin, S. 1996. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2:850–852.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nitsch, R.M., Kim, C. & Growdon, J.H. Vasopressin and Bradykinin Regulate Secretory Processing of the Amyloid Protein Precursor of Alzheimer's Disease. Neurochem Res 23, 807–814 (1998). https://doi.org/10.1023/A:1022423813362
Issue Date:
DOI: https://doi.org/10.1023/A:1022423813362